Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01208493 · ClinicalTrials.gov registry record · NA
Dietary Protein in the Very-low-birth-weight Infant
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Terminated
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT01208493: Clinical Trial NA study, sponsored by Société des Produits Nestlé (SPN).
NCT01208493 is a NA study that was terminated before completion, run by Société des Produits Nestlé (SPN). The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01208493, a NA study, was terminated before completion, sponsored by Société des Produits Nestlé (SPN).
- TERMINATED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula. Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a minimum of 3 weeks. The weight gain (g/d) will be measured and compared between groups. Feeding tolerance, protein-energy status and body composition between the study groups will also be analysed. After discharge, babies will be fed a post-discharge preterm infant formula (PDF) between hospital discharge and 3 m corrected age.
Interventions
- OTHER preterm infant formula with high protein levels
- OTHER preterm standard infant formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2007-09 |
| Est. Completion | 2012-04 |
| Phase | NA |
Why NCT01208493 stopped before completion
NCT01208493 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which preterm infant formula with high protein levels is the first listed.
NCT01208493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01208493 about?
NCT01208493 is a clinical study titled "Dietary Protein in the Very-low-birth-weight Infant". In this randomized study The investigators aim to compare the growth of very-low-birth-weight (VLBW) infants fed either a high protein or a standard protein preterm infant formula. Babies will be fed the assigned formula between the time they achieve full enteral feeds and hospital discharge, for a...
What is the current status of trial NCT01208493?
This trial is currently terminated. It is a NA study. The enrollment target is 70 participants. The study started on 2007-09. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01208493?
The interventions under investigation include: preterm infant formula with high protein levels (OTHER), preterm standard infant formula (OTHER).
Who is sponsoring clinical trial NCT01208493?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01208493's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia